Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia

DS is associated with fibrillar Ab, rCMRgl, and rGMV alterations in the dementia stage and before the presence of clinical decline. This study provides a foundation for the studies needed to inform treatment and prevention in DS.